• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合理开发的聚合物-脂质杂化纳米粒的分子相互作用、内部结构及药物释放动力学

Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.

作者信息

Li Yongqiang, Wong Ho Lun, Shuhendler Adam J, Rauth Andrew M, Wu Xiao Yu

机构信息

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.

出版信息

J Control Release. 2008 May 22;128(1):60-70. doi: 10.1016/j.jconrel.2008.02.014. Epub 2008 Mar 5.

DOI:10.1016/j.jconrel.2008.02.014
PMID:18406489
Abstract

This paper presents the first study of molecular interactions of ingredients and internal nanostructure in relation to drug loading and release mechanisms/kinetics of rationally designed solid polymer-lipid hybrid nanoparticles (PLN). The PLN were prepared by using a rationally selected composition that was found in our previous work to provide optimized interactions of verapamil hydrochloride (VRP) with dextran sulfate sodium (DS) and then the VRP-DS complex with dodecanoic acid (DA). The solid-state properties of the components, their molecular interactions and the morphology, particle size and internal structure of PLN were determined by use of differential scanning calorimetry, powder X-ray diffraction, (13)C nuclear magnetic resonance, Fourier transform infrared spectroscopy, transmission electron microscopy (TEM) and dynamic light scattering. The distribution of VRP in PLN was examined by TEM imaging using a cationic gold tracer. Drug release studies were conducted in various media. Drug loading as high as 36% and loading efficiencies up to 99% were achieved in the rationally formulated PLN. Hydrogen bonding between drug, polymer and lipid and a uniform distribution of amorphous VRP within the solid lipid matrix were evident. Sustained drug release from the PLN was mainly controlled by ion exchange and diffusion processes. The results demonstrated that strong molecular interactions among the drug, the polymer and the lipid in the optimized formulation were responsible for the improved drug loading and release performance of the PLN.

摘要

本文首次研究了合理设计的固体聚合物-脂质杂化纳米粒(PLN)中成分的分子相互作用和内部纳米结构与药物负载及释放机制/动力学之间的关系。PLN是通过使用在我们之前的工作中发现的合理选择的组合物制备的,该组合物能使盐酸维拉帕米(VRP)与硫酸葡聚糖钠(DS)实现优化相互作用,进而使VRP-DS复合物与十二烷酸(DA)相互作用。通过差示扫描量热法、粉末X射线衍射、(13)C核磁共振、傅里叶变换红外光谱、透射电子显微镜(TEM)和动态光散射来测定各组分的固态性质、它们的分子相互作用以及PLN的形态、粒径和内部结构。使用阳离子金示踪剂通过TEM成像检查VRP在PLN中的分布。在各种介质中进行药物释放研究。在合理配制的PLN中实现了高达36%的药物负载量和高达99%的负载效率。药物、聚合物和脂质之间的氢键以及无定形VRP在固体脂质基质中的均匀分布很明显。PLN的持续药物释放主要受离子交换和扩散过程控制。结果表明,优化配方中药物、聚合物和脂质之间强烈的分子相互作用是PLN药物负载和释放性能提高的原因。

相似文献

1
Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.合理开发的聚合物-脂质杂化纳米粒的分子相互作用、内部结构及药物释放动力学
J Control Release. 2008 May 22;128(1):60-70. doi: 10.1016/j.jconrel.2008.02.014. Epub 2008 Mar 5.
2
Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN).脂质载体的筛选以及药物-聚合物-脂质相互作用的表征,用于聚合物-脂质杂化纳米颗粒(PLN)的合理设计。
Pharm Res. 2006 Aug;23(8):1877-87. doi: 10.1007/s11095-006-9033-2.
3
Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation.工程化聚合物-脂质杂化纳米载体用于富马酸替诺福韦二吡呋酯的鼻腔给药:理化性质、分子、微观结构和稳定性评价。
Eur J Pharm Sci. 2015 Apr 25;71:99-111. doi: 10.1016/j.ejps.2015.02.009. Epub 2015 Feb 20.
4
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.通过基于胆酸钠 - 磷脂酰胆碱的混合胶束负载胰岛素的固体脂质纳米粒:制备与表征
Int J Pharm. 2007 Aug 1;340(1-2):153-62. doi: 10.1016/j.ijpharm.2007.03.009. Epub 2007 Mar 12.
5
Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response.包裹有热敏智能聚合物的磁性药物靶向载体:核壳纳米颗粒载体与药物释放响应
Acta Biomater. 2007 Nov;3(6):838-50. doi: 10.1016/j.actbio.2007.05.011. Epub 2007 Jun 29.
6
Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.由固液脂质混合物制成的新型药物纳米载体的设计与表征
J Colloid Interface Sci. 2005 May 15;285(2):590-8. doi: 10.1016/j.jcis.2004.10.012.
7
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.新型聚合物-脂质杂化纳米颗粒(PLN)同时递送阿霉素和GG918(艾拉司群)以增强对多药耐药性乳腺癌的治疗效果。
J Control Release. 2006 Dec 1;116(3):275-84. doi: 10.1016/j.jconrel.2006.09.007. Epub 2006 Sep 26.
8
Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.载帕利哌酮固体脂质纳米粒的制备及表征。
Colloids Surf B Biointerfaces. 2013 Feb 1;102:562-8. doi: 10.1016/j.colsurfb.2012.08.052. Epub 2012 Sep 11.
9
In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.载瑞格列奈聚甲基丙烯酸甲酯纳米粒的体外性质考察及体内毒性研究。
Int J Pharm. 2010 Aug 30;396(1-2):194-203. doi: 10.1016/j.ijpharm.2010.06.023. Epub 2010 Jun 19.
10
Non-destructive methods of characterization of risperidone solid lipid nanoparticles.利培酮固体脂质纳米粒的非破坏性特征描述方法。
Eur J Pharm Biopharm. 2010 Sep;76(1):127-37. doi: 10.1016/j.ejpb.2010.05.003. Epub 2010 May 12.

引用本文的文献

1
Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization.吸入式载伊维菌素脂质聚合物杂化纳米颗粒:研发与表征
Pharmaceutics. 2024 Aug 12;16(8):1061. doi: 10.3390/pharmaceutics16081061.
2
Core-Shell Nanoparticles for Pulmonary Drug Delivery.用于肺部给药的核壳纳米颗粒。
Pharm Nanotechnol. 2025;13(1):90-116. doi: 10.2174/0122117385277725231120043600.
3
Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery.
纳米颗粒成孔剂作为多功能包衣辅料用于口服给药的弱碱性药物pH转变无关型控释的设计与优化
Pharmaceutics. 2023 Feb 7;15(2):547. doi: 10.3390/pharmaceutics15020547.
4
RAFT polymerization mediated core-shell supramolecular assembly of PEGMA--stearic acid block co-polymer for efficient anticancer drug delivery.RAFT聚合介导的聚乙二醇甲基丙烯酸酯-硬脂酸嵌段共聚物核壳超分子组装用于高效抗癌药物递送
RSC Adv. 2021 May 7;11(28):16913-16923. doi: 10.1039/d1ra01660a. eCollection 2021 May 6.
5
Low-Frequency Sonophoresis as an Active Approach to Potentiate the Transdermal Delivery of Agomelatine-Loaded Novasomes: Design, Optimization, and Pharmacokinetic Profiling in Rabbits.低频超声处理增强载阿戈美拉汀诺森osomes 的透皮递送:设计、优化和在兔体内的药代动力学特征。
AAPS PharmSciTech. 2021 Oct 27;22(8):261. doi: 10.1208/s12249-021-02147-y.
6
Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.优化用于将抗癌药物递送至脑胶质瘤的血脑屏障穿透聚合物-脂质杂化纳米粒子的设计。
Pharm Res. 2021 Nov;38(11):1897-1914. doi: 10.1007/s11095-021-03122-9. Epub 2021 Oct 15.
7
Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs.速尿与精氨酸及P-糖蛋白抑制剂药物的共无定形制剂
Pharmaceutics. 2021 Jan 27;13(2):171. doi: 10.3390/pharmaceutics13020171.
8
Influence of Terpene Type on the Release from an O/W Nanoemulsion: Experimental and Theoretical Studies.萜烯类型对 O/W 纳米乳释放的影响:实验和理论研究。
Molecules. 2020 Jun 13;25(12):2747. doi: 10.3390/molecules25122747.
9
Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; the Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity.基于聚己内酯纳米颗粒的长效帕利哌酮注射用制剂;稳定剂和壳聚糖对体外释放、蛋白质吸附及细胞毒性的影响
Pharmaceutics. 2020 Feb 16;12(2):160. doi: 10.3390/pharmaceutics12020160.
10
Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's.抗癫痫-抗炎联合药物的脑靶向隐形脂质体作为传统抗帕金森病治疗的替代疗法
Saudi Pharm J. 2020 Jan;28(1):33-57. doi: 10.1016/j.jsps.2019.11.004. Epub 2019 Nov 13.